These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3043444)

  • 1. A review of the effects of ciglitazone on the pancreatic islets of obese, hyperglycemic mice.
    Diani AR; Sawada GA; Wyse BM
    Prog Clin Biol Res; 1988; 265():193-209. PubMed ID: 3043444
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice.
    Diani AR; Peterson T; Sawada GA; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
    Diabetologia; 1984 Aug; 27(2):225-34. PubMed ID: 6386585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciglitazone, a hypoglycemic agent: early effects on the pancreatic islets of ob/ob mice.
    Colca JR; Wyse BM; Sawada G; Jodelis KS; Connell CL; Fletcher-McGruder BL; Palazuk BJ; Diani AR
    Metabolism; 1988 Mar; 37(3):276-80. PubMed ID: 3278192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice.
    Yen TT; Gill AM; Powell JG; Sampson BM
    Int J Obes Relat Metab Disord; 1992 Nov; 16(11):923-33. PubMed ID: 1337348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoglycemic effect of ciglitazone in obese, hyperglycemic animal models.
    Chang AY; Wyse BM
    Prog Clin Biol Res; 1988; 265():177-92. PubMed ID: 3043443
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects.
    Shargill NS; Tatoyan A; Fukushima M; Antwi D; Bray GA; Chan TM
    Metabolism; 1986 Jan; 35(1):64-70. PubMed ID: 3510364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow mice.
    Gill AM; Yen TT
    Life Sci; 1991; 48(7):703-10. PubMed ID: 1990240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice.
    Sanchez JC; Converset V; Nolan A; Schmid G; Wang S; Heller M; Sennitt MV; Hochstrasser DF; Cawthorne MA
    Mol Cell Proteomics; 2002 Jul; 1(7):509-16. PubMed ID: 12239279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin sensitivity of pancreatic B cells in obese hyperglycemic mice].
    Sodoyez JC; Sodoyez-Goffaux F
    Ann Endocrinol (Paris); 1971; 32(1):199-202. PubMed ID: 4933678
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative histopathological assessment of retardation of islets of langerhans degeneration in rosiglitazone-dosed obese ZDF rats using combined insulin and collagens (I and III) immunohistochemistry with automated image analysis and statistical modeling.
    Jones HB; Bigley AL; Pemberton J; Randall KJ
    Toxicol Pathol; 2013; 41(3):425-44. PubMed ID: 23047688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Troglitazone: its pharmacology and mechanism of action].
    Horikoshi H; Fujiwara T
    Nihon Rinsho; 1997 Nov; 55 Suppl():125-30. PubMed ID: 9434455
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
    Phillips JW; Barringhaus KG; Sanders JM; Yang Z; Chen M; Hesselbacher S; Czarnik AC; Ley K; Nadler J; Sarembock IJ
    Circulation; 2003 Oct; 108(16):1994-9. PubMed ID: 14517165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).
    Sohda T; Meguro K; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2267-78. PubMed ID: 6488400
    [No Abstract]   [Full Text] [Related]  

  • 14. Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation.
    Edvell A; Lindström P
    Am J Physiol; 1998 Jun; 274(6):E1034-9. PubMed ID: 9611153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiology of obese-hyperglycemic mice [ob/ob mice].
    Lindström P
    ScientificWorldJournal; 2007 May; 7():666-85. PubMed ID: 17619751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Gilchrist BJ; Wyse BM
    Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease and benefits of thiazolidinediones.
    Braunstein S
    Postgrad Med; 2003 May; Spec No():45-52. PubMed ID: 12785131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
    Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
    Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of persistent hyperglycemia on transplanted pancreatic islets.
    Jansson L; Korsgren O; Sandler S; Andersson A
    Horm Metab Res Suppl; 1990; 25():137-42. PubMed ID: 2088955
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
    Hofmann CA; Edwards CW; Hillman RM; Colca JR
    Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.